Literature DB >> 32163359

Therapeutic Treatment with Abdominal Adipose Mesenchymal Cells Does Not Prevent Elastase-Induced Emphysema in Rats.

Pınar Yıldız Gülhan1, Mehmet Savaş Ekici2, Mehmet Niyaz3, Muhammet Gülhan4, Mustafa Emre Erçin5, Aydanur Ekici2, Nurkan Aksoy6.   

Abstract

OBJECTIVES: Emphysema and chronic bronchitis have different pathophysiologies but both are significant components of chronic obstructive lung disease (COPD). The levels of Matrix metalloproteinase (MMP)-9 in the bronchoalveloar lavage fluid (BALF) and in serum indicate the presence of emphysema. Intratracheal administration of elastase has been used to create a rat model of emphysema. Adipose tissue-derived mesenchymal stem cells (MSC) have been postulated to prevent or reverse emphysema, however, this has not been examined in the rat model of elastase-induced emphysema.
MATERIALS AND METHODS: In this study, 31 Wistar albino rats aged 6-8 weeks and weighing 250-300 g were assessed. On day 1, the animals were treated intratracheally with 0.5 mL saline (control group, n=10), i.e., 0.5 mL saline solution containing 0.1 IU porcine pancreatic elastase (PPE) (Elastase group, n=12) or PPE plus MSC (Elastase-MSC group, n=9) was adminstered per animal. MSCs suspended in serum were injected via the caudal vein on day 21. At least 106 cells were injected. All animals were sacrificed on day 42 and the emphysema index (EI) was calculated, along with measuring the BALF and serum MMP-9 concentrations.
RESULTS: Porcine pancreatic elastase induced a significant degree of emphysema in the PPE groups as compared to the control group, which was determined by the EI index (p=0.008). This was not reversed by MSC treatment. The EI remained significantly low in comprison with the controls (p=0.001) and measured no different from the Elastase-treated animals. There was no statistically significant difference between the BALF and serum MMP-9 levels between the control and treatment groups.
CONCLUSION: Our findings suggest that therapeutic treatment with adipose tissue-derived MSC in rats has no effect on emphysema or on MMP9 expression, which is a known marker of emphysema.

Entities:  

Year:  2020        PMID: 32163359      PMCID: PMC7020897          DOI: 10.5152/TurkThoracJ.2019.180136

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  52 in total

Review 1.  Therapeutic potential of mesenchymal stem cells for severe acute lung injury.

Authors:  Michael A Matthay; B Taylor Thompson; Elizabeth J Read; David H McKenna; Kathleen D Liu; Carolyn S Calfee; Jae Woo Lee
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

2.  Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.

Authors:  Charlotte E Bolton; Alina A Ionescu; Kathleen M Shiels; Rebecca J Pettit; Peter H Edwards; Michael D Stone; Lisette S Nixon; William D Evans; Timothy L Griffiths; Dennis J Shale
Journal:  Am J Respir Crit Care Med       Date:  2004-09-16       Impact factor: 21.405

3.  Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice.

Authors:  Naveen Gupta; Xiao Su; Boris Popov; Jae Woo Lee; Vladimir Serikov; Michael A Matthay
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

4.  Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood.

Authors:  K Jung; M Lein; C Laube; R Lichtinghagen
Journal:  Clin Chim Acta       Date:  2001-12       Impact factor: 3.786

5.  Matrix metalloproteinase expression and production by alveolar macrophages in emphysema.

Authors:  G A Finlay; L R O'Driscoll; K J Russell; E M D'Arcy; J B Masterson; M X FitzGerald; C M O'Connor
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

Review 6.  Cell therapy approaches for lung diseases: current status.

Authors:  Viranuj Sueblinvong; Daniel J Weiss
Journal:  Curr Opin Pharmacol       Date:  2009-04-06       Impact factor: 5.547

7.  Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema.

Authors:  Kota Ishizawa; Hiroshi Kubo; Mitsuhiro Yamada; Seiichi Kobayashi; Muneo Numasaki; Shinsaku Ueda; Takashi Suzuki; Hidetada Sasaki
Journal:  FEBS Lett       Date:  2004-01-02       Impact factor: 4.124

8.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.

Authors:  M Di Francia; D Barbier; J L Mege; J Orehek
Journal:  Am J Respir Crit Care Med       Date:  1994-11       Impact factor: 21.405

9.  Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors.

Authors:  Xiao-Jun Guan; Lin Song; Feng-Feng Han; Zhi-Lei Cui; Xi Chen; Xue-Jun Guo; Wei-Guo Xu
Journal:  J Cell Biochem       Date:  2013-02       Impact factor: 4.429

10.  Combined Bone Marrow-Derived Mesenchymal Stromal Cell Therapy and One-Way Endobronchial Valve Placement in Patients with Pulmonary Emphysema: A Phase I Clinical Trial.

Authors:  Hugo Goulart de Oliveira; Fernanda Ferreira Cruz; Mariana Alves Antunes; Amarilio Vieira de Macedo Neto; Guilherme Augusto Oliveira; Fabio Munhoz Svartman; Tamara Borgonovo; Carmen Lucia Kuniyoshi Rebelatto; Daniel J Weiss; Paulo Roberto Slud Brofman; Marcelo Marcos Morales; José Roberto Lapa E Silva; Patricia Rieken Macedo Rocco
Journal:  Stem Cells Transl Med       Date:  2016-12-09       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.